NCT06248112View on ClinicalTrials.gov

Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

June 22, 2024

Study Completion Date

July 6, 2024

Conditions

Healthy Subjects

Interventions

DRUG

Sacubitril and Valsartan-Test product

Test-Product: Sacubitril 97 mg and Valsartan 103 mg film-coated tablets Manufactured by: Hetero Labs Ltd., India

DRUG

Sacubitril and Valsartan-Reference product

Reference-product: ENTRESTOTM (Film-Coated Tablets) 97/103 mg Manufactured by: Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd., Singapore for Novartis Pharma AG, Basle, Switzerland

All Listed Sponsors

lead

Bio-innova Co., Ltd

INDUSTRY